145 related articles for article (PubMed ID: 1709237)
1. Electrophysiologic effects and antiarrhythmic efficacy of recainam in patients with supraventricular tachycardia.
Tai YT; Campbell RW; McComb JM
J Cardiovasc Pharmacol; 1991 Feb; 17(2):310-5. PubMed ID: 1709237
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia.
Manz M; Steinbeck G; Lüderitz B
Am J Cardiol; 1985 Oct; 56(10):593-7. PubMed ID: 4050693
[TBL] [Abstract][Full Text] [Related]
3. Clinical electrophysiological effects of intravenous recainam: an antiarrhythmic drug under investigation for the treatment of ventricular and supraventricular arrhythmias.
Feld GK; Luceri RM; Greenspon AJ; Singh BN; Horowitz LN; Capuzzi DM; Frame VB; Myerburg RJ
Pacing Clin Electrophysiol; 1991 Jul; 14(7):1129-37. PubMed ID: 1715550
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia.
Lai WT; Voon WC; Yen HW; Chang JS; Sheu SH; Hwang YS; Chiu HF
Am J Cardiol; 1993 Feb; 71(5):405-8. PubMed ID: 8430627
[TBL] [Abstract][Full Text] [Related]
5. [Cibenzoline: electrophysiologic effects of a new class I anti-arrhythmia agents in supraventricular tachycardia].
Pfitzner P; Manz M; Schütz R; Lüderitz B
Z Kardiol; 1989 Oct; 78(10):654-60. PubMed ID: 2686252
[TBL] [Abstract][Full Text] [Related]
6. Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate.
Kim SS; Lal R; Ruffy R
Am J Cardiol; 1986 Jul; 58(1):80-5. PubMed ID: 3728336
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias.
Fujiki A; Tani M; Mizumaki K; Shimono M; Inoue H
J Cardiovasc Pharmacol; 1994 Mar; 23(3):374-8. PubMed ID: 7515979
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia.
Musto B; D'Onofrio A; Cavallaro C; Musto A; Greco R
Am J Cardiol; 1988 Aug; 62(4):229-33. PubMed ID: 3135739
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiologic effects, clinical efficacy and safety of intravenous and oral nadolol in refractory supraventricular tachyarrhythmias.
Saksena S; Klein GJ; Kowey PR; Calvo RA; Boccadamo R; Brown JE; Sharma AD; Gadhoke A; Olukotun AY
Am J Cardiol; 1987 Feb; 59(4):307-12. PubMed ID: 3812280
[TBL] [Abstract][Full Text] [Related]
10. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
Kühlkamp V; Ickrath O; Schmid F; Mayer F; Haasis R; Seipel L
Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of intravenous and oral betaxolol on antegrade and retrograde conduction in patients with atrioventricular nodal reentrant and atrioventricular reentrant tachycardia.
Kühlkamp V; Ickrath O; Haasis R; Seipel L
Eur Heart J; 1989 Jun; 10(6):493-501. PubMed ID: 2569398
[TBL] [Abstract][Full Text] [Related]
12. Nadolol and supraventricular tachycardia: an electrophysiologic study.
Chang MS; Sung RJ; Tai TY; Lin SL; Liu PH; Chiang BN
J Am Coll Cardiol; 1983 Nov; 2(5):894-903. PubMed ID: 6138376
[TBL] [Abstract][Full Text] [Related]
13. [Electrophysiologic effects of betaxolol on conduction properties of the antegrade and retrograde pathway in patients with typical atrioventricular node reentry tachycardia following intravenous and oral administration].
Kühlkamp V; Ickrath O; Haasis R; Seipel L
Z Kardiol; 1988 Aug; 77(8):527-33. PubMed ID: 3176596
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
Hellestrand KJ
Am J Cardiol; 1996 Jan; 77(3):83A-88A. PubMed ID: 8607396
[TBL] [Abstract][Full Text] [Related]
15. Ethmozin. II. Effects of intravenous drug administration on atrioventricular nodal reentrant tachycardia.
Chazov EI; Rosenshtraukh LV; Shugushev KK
Am Heart J; 1984 Sep; 108(3 Pt 1):483-9. PubMed ID: 6382989
[TBL] [Abstract][Full Text] [Related]
16. [Electrophysiologic effects of penticainide in patients with supraventricular tachycardia].
Kühlkamp V; Mewis C; Mayer F; Seipel L
Z Kardiol; 1990 Oct; 79(10):725-31. PubMed ID: 2087860
[TBL] [Abstract][Full Text] [Related]
17. [Clinical electrophysiologic effects of lorcainide in patients and its effect on the conduction of accessory pathway in Wolff-Parkinson-White syndrome].
Jiang H
Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Jun; 18(3):157-9, 190. PubMed ID: 2086169
[TBL] [Abstract][Full Text] [Related]
18. Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias.
Hellestrand KJ; Nathan AW; Bexton RS; Spurrell RA; Camm AJ
Am J Cardiol; 1983 Mar; 51(5):770-6. PubMed ID: 6829436
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of intravenous magnesium on atrioventricular node conduction in supraventricular tachycardia.
Stiles MK; Sanders P; Disney P; Brooks A; John B; Lau DH; Shashidhar ; Wilson L; Mackenzie L; Young GD
Am J Cardiol; 2007 Oct; 100(8):1249-53. PubMed ID: 17920366
[TBL] [Abstract][Full Text] [Related]
20. Ethmozin. I. Effects of intravenous drug administration on paroxysmal supraventricular tachycardia in the ventricular preexcitation syndrome.
Chazov EI; Shugushev KK; Rosenshtraukh LV
Am Heart J; 1984 Sep; 108(3 Pt 1):475-82. PubMed ID: 6382988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]